Connect with us

California

Biocom California Statement on New Drug Pricing Legislation

Published

on

Biocom California Statement on New Drug Pricing Legislation


SOUTH SAN FRANCISCO, LOS ANGELES, SAN DIEGO & WASHINGTON–(BUSINESS WIRE)–Biocom California, the affiliation representing the life science trade of California, issued the next assertion concerning the drug pricing portion within the Inflation Discount Act. The assertion might be attributed to Joe Panetta, Biocom California’s president and CEO:

After an in depth evaluation and consideration of the drug pricing provisions included within the Inflation Discount Act, we at Biocom California don’t have any different selection than to oppose this laws, because it as soon as once more comes in need of defending innovation and making significant modifications for sufferers.

Whereas we wholeheartedly assist the provisions within the invoice that set up a a lot wanted $2,000 cap on out-of-pocket affected person spending and restructure of the Medicare Half D profit program, we’re deeply involved that the invoice ignores the tireless work of well-informed lawmakers who put ahead options that struck a fragile stability between selling affected person affordability and recognizing the function of the biomedical innovation group in bringing progressive medicines to market.

We respect that the invoice doesn’t embrace international worth controls, but it surely nonetheless provides the federal authorities unilateral dedication over the worth of a medication and, if an organization doesn’t agree with that valuation, it will be successfully barred from your complete Medicare market. That is pure authorities worth setting, not negotiation.

Advertisement

The invoice would impression not solely the medication chosen for ‘negotiation,’ but additionally future medicines that depend on risk-averse investments to be developed. Worth controls have been confirmed to destabilize innovation ecosystems by driving capital investments away, chilling analysis and improvement, and eliminating jobs. In the end, they scale back the variety of medicines being developed and reaching sufferers.

A latest research by Very important Transformation has estimated that the invoice would scale back innovators’ income by at the very least 55%, placing 104 out of 110 medication or 95% of the pipeline susceptible to cancelled improvement, and costing California over 100,000 jobs. California is the worldwide chief in biomedical innovation and a significant contributor to the state’s financial system, producing over $400 billion in annual financial exercise and supporting virtually 1.4 million jobs. As such, California firms and the state’s total financial system might be disproportionately harmed, particularly small firms that create greater than half of recent medicines.

The invoice additionally ignores repeated calls from greater than 130 affected person organizations to bar the federal authorities from utilizing worth setting methodologies that ration care and discriminate in opposition to seniors and people with disabilities.

Final however not least, the invoice would take away virtually $300 billion in trade income to cut back federal authorities prescription drug spending. But, there’s completely nothing within the invoice that requires the federal authorities to move a penny of those ‘financial savings’ right down to sufferers. As a substitute, they’re supposed to cut back the budgetary impression of unrelated provisions within the invoice that paradoxically spend money on different analysis and manufacturing industries, successfully selecting winners and losers.

After years of debate and factual enter from our trade, the affected person group and legislators with deep technical data of the innovation ecosystem, it’s alarming that Congress is pursuing one other drug pricing proposal that endorses worth setting and fails to acknowledge the function of scientific discovery, regardless of our profitable work to deal with the COVID-19 pandemic. As all the time, we stand able to work with Congress to enact bipartisan proposals that meaningfully deal with inefficiencies inside the well being care system and convey all stakeholders to the desk.”

Advertisement

About Biocom California

Biocom California is the chief and advocate for California’s life science sector. We work on behalf of greater than 1,600 members to drive public coverage, construct an enviable community of trade leaders, create entry to capital, introduce cutting-edge STEM teaching programs and create sturdy value-driven buying packages.

Based in 1995 in San Diego, Biocom California offers the strongest public voice to analysis establishments and corporations that gas the native and state-wide financial system. Our purpose is straightforward: to assist our members produce novel options that enhance the human situation. Along with our San Diego headquarters, Biocom California operates core workplaces in Los Angeles and the San Francisco Bay Space, with satellite tv for pc workplaces in Sacramento, Washington, D.C. and Tokyo. Our broad membership advantages apply to biotechnology, pharmaceutical, medical gadget, genomics and diagnostics firms of all sizes, in addition to to analysis universities and institutes, scientific analysis organizations, buyers and repair suppliers.

For extra data on Biocom California, please go to our web site at www.biocom.org. Join with us on LinkedIn, Fb, and Twitter (@BIOCOMCA).

Advertisement





Source link

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

California

California proposes its own EV buyer credit — which could cut out Elon Musk's Tesla

Published

on

California proposes its own EV buyer credit — which could cut out Elon Musk's Tesla


  • Gov. Gavin Newsom plans to revive California’s EV rebate if Trump ends the federal tax credit.
  • But Tesla, the largest maker of EVs, would be excluded under the proposal.
  • Elon Musk criticized Tesla’s potential exclusion from the rebate.

California Gov. Gavin Newsom is preparing to step in if President-elect Donald Trump fulfills his promise to axe the federal electric-vehicle tax credit — but one notable EV maker could be left out.

Newsom said Monday if the $7,500 federal tax credit is eliminated he would restart the state’s zero-emission vehicle rebate program, which was phased out in 2023.

“We will intervene if the Trump Administration eliminates the federal tax credit, doubling down on our commitment to clean air and green jobs in California,” Newsom said in a statement. “We’re not turning back on a clean transportation future — we’re going to make it more affordable for people to drive vehicles that don’t pollute.”

Advertisement

The rebates for EV buyers would come from the state’s Greenhouse Gas Reduction Fund, which is funded by polluters of greenhouse gases under a cap-and-trade program, according to the governor’s office.

But Tesla’s vehicles could be excluded under the proposal’s market-share limitations, Bloomberg News first reported.

The governor’s office confirmed to Business Insider that the rebate program could include a market-share cap which could in turn exclude Tesla or other EV makers. The office did not share details about what market-share limit could be proposed and also noted the proposal would be subject to negotiations in the state legislature.

A market-share cap would exclude companies whose sales account for a certain amount of total electric vehicle sales. For instance, Tesla accounted for nearly 55% off all new electric vehicles registered in California in the first three quarters of 2024, according to a report from the California New Car Dealers Association. By comparison, the companies with the next highest EV market share in California were Hyundai and BMW with 5.6% and 5% respectively.

Advertisement

Tesla sales in California, the US’s largest EV market, have recently declined even as overall EV sales in the state have grown. Though the company still accounted for a majority of EV sales in California this year as of September, its market share fell year-over-year from 64% to 55%.

The governor’s office said the market-share cap would be aimed at promoting competition and innovation in the industry.

Elon Musk, who has expressed support for ending the federal tax credit, said in an X post it was “insane” for the California proposal exclude Tesla.

The federal electric vehicle tax credit, which was passed as part of the Biden administration’s Inflation Reduction Act in 2022, provides a $7,500 tax credit to some EV buyers.

Advertisement

Musk, who is working closely with the incoming Trump administration, has expressed support for ending the tax credit. He’s set to co-lead an advisory commission, the Department of Government Efficiency, which is aimed at slashing federal spending.

The Tesla CEO said on an earnings call in July that ending the federal tax credit might actually benefit the company.

“I think it would be devastating for our competitors and for Tesla slightly,” Musk said. “But long-term probably actually helps Tesla, would be my guess.”

Advertisement

BI’s Graham Rapier previously reported that ending the tax credit could help Tesla maintain its strong standing in the EV market by slowing its competitors growth.

Prior to the EV rebate proposal, Newsom has already positioned himself as a foil to the incoming Trump administration. Following Trump’s election win the governor called on California lawmakers to convene for a special session to discuss protecting the state from Trump’s second term.

“The freedoms we hold dear in California are under attack — and we won’t sit idle,” Newsom said in a statement at the time.





Source link

Advertisement
Continue Reading

California

California Gov. Gavin Newsom says state will provide rebates if Trump removes tax credit for electric vehicles

Published

on

California Gov. Gavin Newsom says state will provide rebates if Trump removes tax credit for electric vehicles


California Gov. Gavin Newsom said the state will provide rebates to residents if President-elect Donald Trump’s incoming administration does away with a federal tax credit for electric vehicles.

In a news release issued Monday, Newsom said he would restart the state’s Clean Vehicle Rebate Program, which provided financial incentives on more than 590,000 vehicles before it was phased out late 2023.

“We will intervene if the Trump Administration eliminates the federal tax credit, doubling down on our commitment to clean air and green jobs in California,” Newsom said. “We’re not turning back on a clean transportation future — we’re going to make it more affordable for people to drive vehicles that don’t pollute.”

The federal rebates on new and used electric vehicles were implemented in the Inflation Reduction Act that President Joe Biden signed into law in 2022. When Trump’s second term in office begins next year, he could work with Congress to change the rules around those rebates. Those potential changes could limit the federal rebates, including by reducing the amount of money available or limiting who is eligible.

Advertisement

Limiting federal subsidies on electric vehicle purchases would hurt many American automakers, including Ford, General Motors and the EV startup Rivian. Tesla, which also builds its automobiles in the United States, would take a smaller hit since that company currently sells more EVs and has a higher profit margin than any other EV manufacturer.

Newsom also announced earlier this month that he will convene a special session “to protect California values,” including fundamental civil rights and reproductive rights, that he said “are under attack by this incoming administration.”

“Whether it be our fundamental civil rights, reproductive freedom, or climate action — we refuse to turn back the clock and allow our values and laws to be attacked,” Newsom said on X on Nov. 7.

A spokesperson for Trump did not immediately respond to a request for comment.

This isn’t the first time California will be taking action against the Trump’s administration concerning clean transportation legislation.

Advertisement

In 2019, California and 22 other states sued his administration for revoking its ability to set standards for greenhouse gas emission and fuel economy standards for vehicles, The Associated Press reported.

California sued the Trump administration over 100 times during his first term, primarily on matters including gun control, health care, education and immigration, the Los Angeles Times reported.



Source link

Continue Reading

California

45 Years Later, California Murder Mystery Solved Through DNA Evidence

Published

on

45 Years Later, California Murder Mystery Solved Through DNA Evidence


A 45-year-old cold case of a 17-year-old girl brutally raped and murdered has been resolved, bringing closure to the family. On February 9, 1979, Esther Gonzalez walked from her parents’ home to her sister’s in Banning, California, roughly 137 km east of Los Angeles. She never arrived. The next day, her body was discovered in a snowpack near a highway in Riverside County, California. Authorities determined she had been raped and bludgeoned to death, leading to an investigation that spanned decades.

The lab was able to match the DNA to a man named Lewis Randolph “Randy” Williamson, who died in 2014. Williamson, a US Marine Corps veteran, called authorities on the fateful day to report finding Ms Gonzalez’s body. At the time, he claimed he could not identify whether the body was male or female. Described as “argumentative” by deputies, Williamson was asked to take a polygraph test, which he passed, clearing him of suspicion in the pre-DNA era. He had faced assault allegations in the past but was never convicted of any violent crimes, according to the Los Angeles Times.

Advertisement

Despite limited leads, the Riverside County cold case homicide team didn’t give up. A semen sample recovered from Ms Gonzalez’s body in 1979 was preserved but remained unmatched in the national Combined DNA Index System (CODIS) for decades.

In 2023, forensic technology finally caught up. The homicide team collaborated with a genetic lab in Texas that specialises in forensic genealogy. A sample of Williamson’s blood from his 2014 autopsy provided the DNA match needed to confirm him as the 17-year-old’s rapist and killer.

The Gonzalez family had mixed emotions—relief at finally having answers and sadness knowing Williamson would not face justice, as he died in Florida ten years ago. Ms Gonzalez, remembered by her family as a shy yet funny and mild-mannered young woman, was the fourth of seven children. Her oldest brother, Eddie Gonzalez, wrote on Facebook, “The Gonzalez family would like to thank the Riverside County Sheriff’s Department on a job well done. After 40 years, the Gonzalez family has closure.”

Advertisement

“We are very happy that we finally have closure,” Ms Gonzalez’s sister, Elizabeth, 64, shared with CNN. “We are happy about it but, since the guy has died, a little sad that he won’t spend any time for her murder.”




Source link

Advertisement
Continue Reading

Trending